These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12908783)

  • 21. Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage.
    Ohshima K; Suzumiya J; Shimazaki K; Kato A; Tanaka T; Kanda M; Kikuchi M
    Histopathology; 1997 Nov; 31(5):444-50. PubMed ID: 9416485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas.
    Lien HC; Lin CW; Huang PH; Chang ML; Hsu SM
    Lab Invest; 2000 Jun; 80(6):893-900. PubMed ID: 10879740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.
    Mori N; Yatabe Y; Oka K; Kinoshita T; Kobayashi T; Ono T; Asai J
    Am J Pathol; 1996 Aug; 149(2):699-705. PubMed ID: 8702007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.
    Quintanilla-Martinez L; Kremer M; Keller G; Nathrath M; Gamboa-Dominguez A; Meneses A; Luna-Contreras L; Cabras A; Hoefler H; Mohar A; Fend F
    Am J Pathol; 2001 Dec; 159(6):2095-105. PubMed ID: 11733360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
    Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
    Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
    Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
    Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
    Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.
    Suzumiya J; Ohshima K; Takeshita M; Kanda M; Kawasaki C; Kimura N; Tamura K; Kikuchi M
    Leuk Lymphoma; 1999 Nov; 35(5-6):567-78. PubMed ID: 10609794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study].
    Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L
    Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
    Ng CS; Lo ST; Chan JK; Chan WC
    Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological features of Epstein-Barr virus-associated nasal T/NK cell lymphomas in southern Japan.
    Seki D; Ueno K; Kurono Y; Eizuru Y
    Auris Nasus Larynx; 2001 Jan; 28(1):61-70. PubMed ID: 11137365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
    Schwartz EJ; Molina-Kirsch H; Zhao S; Marinelli RJ; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2008 Sep; 130(3):343-51. PubMed ID: 18701406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
    Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
    Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
    Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1.
    Kim JE; Kim YA; Jeon YK; Park SS; Heo DS; Kim CW
    Pathol Int; 2003 Nov; 53(11):735-43. PubMed ID: 14629296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.